SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Boston Scientific
BSX 100.68+0.1%11:07 AM EDT
 Public ReplyPrvt ReplyMark as Last ReadFileNext 10PreviousNext  
From: telephonics10/30/2004 8:42:08 AM
   of 20
 
The shock of the stent problems is now largely past and the emerging money maker is the growing sales of the Prolieve treatment for Benign Prostatic Hyperplasia. Rapidly pushing other treatments out of this huge market. Prolieve is an FDA approved procedure pioneered by Celsion (CLN AMEX)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFileNext 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News